Target Name: LOC100130691
NCBI ID: G100130691
Review Report on LOC100130691 Target / Biomarker Content of Review Report on LOC100130691 Target / Biomarker
LOC100130691
Other Name(s): Putative uncharacterized protein FLJ44553

LOC100130691: A Drug Target / Disease Biomarker

LOC100130691 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the LOC1001 family of proteins, which are known to play a role in cell signaling. LOC100130691 has been identified as a potential drug target due to its unique structure and the involvement of certain diseases, such as cancer and neurodegenerative diseases.

The LOC100130691 protein is composed of 214 amino acid residues and has a calculated molecular mass of 33.1 kDa. It is expressed in a variety of tissues, including the brain, heart, and kidneys, and is also found in the placenta and testes. LOC100130691 is a member of the LOC1001 family of proteins, which are known to play a role in cell signaling. This family of proteins includes the LOC100130692 protein, which is also known as GLUT1.

GLUT1 is a transmembrane protein that is expressed in various tissues of the body. It is involved in the regulation of cell signaling and has been implicated in a number of diseases, including cancer. LOC100130691 and GLUT1 share several conserved amino acid residues, including a glutamic acid residue at position 124, which is known to be a critical residue for protein-protein interactions.

One of the unique features of LOC100130691 is its structure. LOC100130691 has a unique fusiform structure, which is characterized by a long, slender body and a narrow neck that connects the body to the head. This structure is unique among proteins and allows LOC100130691 to interact with other proteins in a specific way.

The involvement of LOC100130691 in disease is an attractive feature for drug development. LOC100130691 has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and obesity. For example, LOC100130691 has been shown to be overexpressed in various types of cancer, including breast, lung, and colorectal cancer. This suggests that LOC100130691 may play a role in the development and progression of these diseases.

In addition to its potential role in disease, LOC100130691 also has unique properties that make it an attractive drug target. For example, LOC100130691 is a protein that is expressed in various tissues of the body, which makes it an attractive target for drugs that can cross the blood-brain barrier. Additionally, LOC100130691 has a unique structure that allows it to interact with other proteins in a specific way. This makes it an attractive target for drugs that can modulate protein-protein interactions.

In conclusion, LOC100130691 is a protein that has unique properties and is expressed in various tissues of the body. Its structure and the involvement of GLUT1 in cell signaling make it an attractive drug target for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of LOC100130691 in disease and to develop effective treatments.

Protein Name: Putative Uncharacterized Protein FLJ44553

The "LOC100130691 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100130691 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC100130698 | LOC100130744 | LOC100130748 | LOC100130872 | LOC100130899 | LOC100130938 | LOC100130987 | LOC100130992 | LOC100131096 | LOC100131107 | LOC100131257 | LOC100131289 | LOC100131372 | LOC100131496 | LOC100131532 | LOC100131626 | LOC100131635 | LOC100131859 | LOC100131877 | LOC100131943 | LOC100132004 | LOC100132062 | LOC100132077 | LOC100132078 | LOC100132249 | LOC100132287 | LOC100132356 | LOC100132609 | LOC100132626 | LOC100132651 | LOC100132686 | LOC100132741 | LOC100132781 | LOC100132797 | LOC100133077 | LOC100133165 | LOC100133177 | LOC100133284 | LOC100133331 | LOC100133920 | LOC100134317 | LOC100134368 | LOC100134391 | LOC100134868 | LOC100190986 | LOC100233156 | LOC100240728 | LOC100240734 | LOC100240735 | LOC100271840 | LOC100272216 | LOC100272217 | LOC100286922 | LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023 | LOC100506071 | LOC100506076 | LOC100506124 | LOC100506207 | LOC100506236